130 related articles for article (PubMed ID: 19338533)
1. Prognostic factors in malignant ureteric obstruction.
Lienert A; Ing A; Mark S
BJU Int; 2009 Oct; 104(7):938-41. PubMed ID: 19338533
[TBL] [Abstract][Full Text] [Related]
2. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
[TBL] [Abstract][Full Text] [Related]
3. Clinical Factors Associated With a Short Survival Time After Percutaneous Nephrostomy for Ureteric Obstruction in Cancer Patients: An Updated Model.
Alawneh A; Tuqan W; Innabi A; Al-Nimer Y; Azzouqah O; Rimawi D; Taqash A; Elkhatib M; Klepstad P
J Pain Symptom Manage; 2016 Feb; 51(2):255-61. PubMed ID: 26497918
[TBL] [Abstract][Full Text] [Related]
4. The role of percutaneous nephrostomy in malignant ureteric obstruction.
Wilson JR; Urwin GH; Stower MJ
Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
[TBL] [Abstract][Full Text] [Related]
5. Use of nephrostomy tubes in ureteric obstruction from incurable malignancy.
Little B; Ho KJ; Gawley S; Young M
Int J Clin Pract; 2003 Apr; 57(3):180-1. PubMed ID: 12723719
[TBL] [Abstract][Full Text] [Related]
6. The outcome with ureteric stents for managing non-urological malignant ureteric obstruction.
Jeong IG; Han KS; Joung JY; Seo HK; Chung J
BJU Int; 2007 Dec; 100(6):1288-91. PubMed ID: 17850371
[TBL] [Abstract][Full Text] [Related]
7. Malignant ureteral obstruction: outcomes after intervention. Have things changed?
Wong LM; Cleeve LK; Milner AD; Pitman AG
J Urol; 2007 Jul; 178(1):178-83; discussion 183. PubMed ID: 17499300
[TBL] [Abstract][Full Text] [Related]
8. A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients.
Cordeiro MD; Coelho RF; Chade DC; Pessoa RR; Chaib MS; Colombo-Júnior JR; Pontes-Júnior J; Guglielmetti GB; Srougi M
BJU Int; 2016 Feb; 117(2):266-71. PubMed ID: 25327474
[TBL] [Abstract][Full Text] [Related]
9. Prognostic marker for patients with malignant ureter obstruction.
Azuma T; Nagase Y; Oshi M
Clin Genitourin Cancer; 2013 Sep; 11(3):353-6. PubMed ID: 23787166
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?
Ku JH; Lee SW; Jeon HG; Kim HH; Oh SJ
Urology; 2004 Nov; 64(5):895-9. PubMed ID: 15533473
[TBL] [Abstract][Full Text] [Related]
11. [Relief of upper urinary tract obstruction in patients with cancer of the prostate].
Kraemer PC; Borre M
Ugeskr Laeger; 2009 Mar; 171(11):873-6. PubMed ID: 19278608
[TBL] [Abstract][Full Text] [Related]
12. Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site.
Seve P; Ray-Coquard I; Trillet-Lenoir V; Sawyer M; Hanson J; Broussolle C; Negrier S; Dumontet C; Mackey JR
Cancer; 2006 Dec; 107(11):2698-705. PubMed ID: 17063500
[TBL] [Abstract][Full Text] [Related]
13. Ureteric obstruction in familial adenomatous polyposis-associated desmoid disease.
Joyce M; Mignanelli E; Church J
Dis Colon Rectum; 2010 Mar; 53(3):327-32. PubMed ID: 20173481
[TBL] [Abstract][Full Text] [Related]
14. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
15. Impact of hydronephrosis on outcome of stage IIIB cervical cancer patients with disease limited to the pelvis, treated with radiation and concurrent chemotherapy: a Gynecologic Oncology Group study.
Rose PG; Ali S; Whitney CW; Lanciano R; Stehman FB
Gynecol Oncol; 2010 May; 117(2):270-5. PubMed ID: 20181381
[TBL] [Abstract][Full Text] [Related]
16. The management of malignant ureteral obstruction treated with ureteral stents.
Ganatra AM; Loughlin KR
J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
[TBL] [Abstract][Full Text] [Related]
17. [Results of radiotherapy of ureteral obstruction in invasive bladder cancer].
Holm M; Miskowiak J; Rolff H
Ugeskr Laeger; 1996 Jan; 158(4):420-1. PubMed ID: 8638301
[TBL] [Abstract][Full Text] [Related]
18. Current outcome of patients with ureteral stents for the management of malignant ureteral obstruction.
Izumi K; Mizokami A; Maeda Y; Koh E; Namiki M
J Urol; 2011 Feb; 185(2):556-61. PubMed ID: 21168872
[TBL] [Abstract][Full Text] [Related]
19. [Endo-urological drainage in urinary outflow obstruction caused by cancer].
Stevens A; van Driel MF; Klein JP; de Ruiter AJ; Mensink HJ
Ned Tijdschr Geneeskd; 1994 Mar; 138(10):522-5. PubMed ID: 8139712
[TBL] [Abstract][Full Text] [Related]
20. [Endoluminal therapy for bilateral malignant ureteric obstruction].
Liu YD; Yuan J; Huang ST; Luo JT; Zeng GH; Xun L
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):717-9. PubMed ID: 18246808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]